COMMUNIQUÉ DE PRESSE publié le 07/03/2024 à 12:30, il y a 2 années 3 mois Zomedica Announces Publication of Case Series Highlighting Success with PulseVet(R) Shock Wave Therapy for Difficult to Treat Fibrotic Myopathy in Working Dogs Zomedica Corp. announced the publication of a case series supporting PulseVet shock wave therapy in treating canine fibrotic myopathy. The study shows improved working life for affected dogs Zomedica Corp. Veterinary Health PulseVet Shock Wave Therapy Canine Fibrotic Myopathy Animal Healthcare
BRÈVE publiée le 05/03/2024 à 12:35, il y a 2 années 3 mois Zomedica to Present at the Sidoti Small Cap Conference March 14, 2024 Zomedica Veterinary Health Sidoti Small Cap Conference Investor Meetings Webcast Replay
BRÈVE publiée le 05/03/2024 à 12:35, il y a 2 années 3 mois Zomedica fera une présentation à la conférence Sidoti Small Cap le 14 mars 2024 Zomedica Santé Vétérinaire Conférence Sidoti Small Cap Réunions D'investisseurs Rediffusion De La Webdiffusion
COMMUNIQUÉ DE PRESSE publié le 05/03/2024 à 12:30, il y a 2 années 3 mois Zomedica to Present at the Sidoti Small Cap Conference March 14, 2024 Zomedica Corp. to present at Sidoti Small Cap Conference on March 14, 2024. Learn about the company's focus on veterinary health products for animals Investors Zomedica Corp. Veterinary Health Sidoti Small Cap Conference Animals
COMMUNIQUÉ DE PRESSE publié le 08/02/2024 à 12:30, il y a 2 années 4 mois Zomedica Announces Sponsorship of Educational Presentations at Major Veterinary Health Conferences Zomedica Corp. continues its veterinary education mission with recent and upcoming presentations at VMX and WVC meetings. Zomedica offers diagnostic and therapeutic products for equine and companion animals Zomedica Corp Veterinary Education Diagnostic Products Therapeutic Products VMX Meetings
COMMUNIQUÉ DE PRESSE publié le 06/02/2024 à 22:30, il y a 2 années 4 mois Leading Independent Proxy Advisory Firm Glass Lewis Recommends Zomedica Shareholders Vote for the Share Consolidation (Reverse Stock Split) Zomedica Corp receives favorable recommendations from Glass Lewis for proposed Share Consolidation/Reverse Stock Split. ISS also supports the move, recognizing its potential benefits. Special Virtual-only Meeting of Shareholders scheduled for February 28, 2024 Zomedica Corp Share Consolidation Reverse Stock Split Glass Lewis Special Meeting Of Shareholders
COMMUNIQUÉ DE PRESSE publié le 06/02/2024 à 12:30, il y a 2 années 4 mois Zomedica to Host Virtual Investor Day February 13 at 3:00 p.m. ET Zomedica Corp. to host Virtual Investor Day 2024 on February 13, featuring presentations on innovative products, business developments, and future growth drivers Veterinary Health Company Innovative Products Zomedica Corp. Virtual Investor Day 2024 Animal Health
COMMUNIQUÉ DE PRESSE publié le 31/01/2024 à 12:30, il y a 2 années 4 mois Open Letter to Zomedica Shareholders from your Chief Executive Officer Zomedica Corp. CEO Larry Heaton issues open letter to shareholders urging vote FOR upcoming reverse split, highlighting potential benefits. Encourages due diligence before voting Shareholders Zomedica Corp. Larry Heaton Reverse Split Due Diligence
COMMUNIQUÉ DE PRESSE publié le 30/01/2024 à 12:30, il y a 2 années 4 mois Zomedica to Participate in the Lytham Partners 2024 Investor Select Conference Zomedica Corp. will participate in fireside chat and one-on-one meetings at Lytham Partners 2024 Investor Select Conference. Webcast at 10:15am ET on February 1st, 2024 Veterinary Health Company Webcast Lytham Partners 2024 Investor Select Conference Zomedica Corp. Fireside Chat
COMMUNIQUÉ DE PRESSE publié le 25/01/2024 à 22:35, il y a 2 années 4 mois Leading Proxy Advisory Firm ISS Recommends Zomedica Shareholders Vote "FOR" Proposed Reverse Stock Split Zomedica Corp. announces ISS recommendation for the proposed Share Consolidation/Reverse Stock Split to maintain NYSE American listing. Special Virtual-only Meeting of Shareholders to be held on February 28, 2024, at 1:00 pm EST. Share Consolidation Reverse Stock Split Zomedica Corp. ISS Recommendation NYSE American Listing
Publié le 19/06/2026 à 19:33, il y a 1 jour 19 heures Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Publié le 19/06/2026 à 19:33, il y a 1 jour 19 heures Disclosure of transactions in own shares from June 15 to June 19, 2026
Publié le 19/06/2026 à 19:23, il y a 1 jour 19 heures Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026
Publié le 19/06/2026 à 19:23, il y a 1 jour 19 heures Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
Publié le 20/06/2026 à 01:00, il y a 1 jour 13 heures Onco-Innovations Announces Non-Brokered LIFE Offering
Publié le 20/06/2026 à 00:00, il y a 1 jour 14 heures Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Publié le 19/06/2026 à 04:30, il y a 2 jours 10 heures Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Publié le 19/06/2026 à 01:20, il y a 2 jours 13 heures American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Publié le 19/06/2026 à 01:07, il y a 2 jours 13 heures Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting
Publié le 20/06/2026 à 21:25, il y a 17 heures 8 minutes VIVATECH 2026 CELEBRATES ITS 10TH ANNIVERSARY WITH A RECORD EDITION SURPASSING 200,000 VISITORS
Publié le 20/06/2026 à 06:00, il y a 1 jour 8 heures Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Publié le 19/06/2026 à 20:17, il y a 1 jour 18 heures 2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Publié le 19/06/2026 à 20:17, il y a 1 jour 18 heures 2CRSi SA: 2CRSi répond point par point au rapport de Grizzly Research et réaffirme la réalité de son activité
Publié le 19/06/2026 à 19:01, il y a 1 jour 19 heures Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting